Products for Research Use Only
RegisterLogin

AS601245

CAT: 0804-HY-11010-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-11010-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
AS601245 is an orally active, selective, ATP competitive JNK (c-Jun NH2-terminal protein kinase) inhibitor with IC50s of 150, 220, and 70 nM for three JNK human isoforms (hJNK1, hJNK2, and hJNK3), respectively. AS601245 exhibits 10- to 20-fold selectivity over c-src, CDK2, and c-Raf and more than 50- to 100-fold selectivity over a range of Ser/Thr- and Tyr-protein kinases. Neuroprotective properties[1][2].
CAS Number
345987-15-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
JNK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/AS601245.html
Concentration
10mM
Purity
98.19
Solubility
DMSO : 10 mg/mL (ultrasonic)
Smiles
N#CC(C1=CC=NC(NCCC2=CC=CN=C2)=N1)C3=NC4=CC=CC=C4S3
Molecular Formula
C20H16N6S
Molecular Weight
372.45
Precautions
H302, H315, H319, H335
References & Citations
[1]Carboni S, et al. AS601245 (1,3-benzothiazol-2-yl (2-[[2- (3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile) : a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties. J Pharmacol Exp Ther. 2004;310 (1) :25-32.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JNK1; JNK2; JNK3

Alternative Products

CatalogName
B5942-5.1AS601245
M22390-01AS601245.2TFA
A21502-100AS601245 100mg
A21502-25AS601245 25mg
A21502-5AS601245 5mg

Popular Products